Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00635934 · ClinicalTrials.gov registry record · NA
A-MAV™ Anterior Motion Segment Replacement
A NA study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT00635934 is a NA study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 53 participants.
The verdict
NCT00635934, a NA study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to collect safety and effectiveness data concerning the A-MAV™ Anterior Motion Segment Replacement device as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1. Overall success will be the primary clinical endpoint.
Interventions
- DEVICE A-MAV™ disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2005-12 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00635934
The ClinicalTrials.gov registry entry for NCT00635934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A-MAV™ disc is the first listed.
NCT00635934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00635934 about?
NCT00635934 is a clinical study titled "A-MAV™ Anterior Motion Segment Replacement". The purpose of this clinical trial is to collect safety and effectiveness data concerning the A-MAV™ Anterior Motion Segment Replacement device as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1. Overall success will be the primary clinical endpoint.
What is the current status of trial NCT00635934?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2005-12. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00635934?
The interventions under investigation include: A-MAV™ disc (DEVICE).
Who is sponsoring clinical trial NCT00635934?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.